Home NDC 68682-708-90 Diltiazem Hydrochloride
Product NDC 68682-708
Requested package NDC 68682-708-90
11-digit product format 686820708
Labeler code 68682
Product ID 68682-708_9c3468f2-1199-4180-9e57-089b5353251a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Diltiazem Hydrochloride Extended-Release Tablets
Dosage form TABLET, EXTENDED RELEASE
Route ORAL
Labeler Oceanside Pharmaceuticals
Application NDA021392
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2014-02-06
Substance DILTIAZEM HYDROCHLORIDE
Active strength 360 mg/1
Pharmacologic classes Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021392-001 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 N021392-002 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 N021392-003 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 N021392-004 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 N021392-005 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 N021392-006 CARDIZEM LA DILTIAZEM HYDROCHLORIDE 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 270 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-005 CARDIZEM LA 360MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021392-006 CARDIZEM LA 420MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2003-02-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021392-001 CARDIZEM LA 120MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021392-002 CARDIZEM LA 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021392-003 CARDIZEM LA 240MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021392-004 CARDIZEM LA 300MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2003-02-06 6a471c1ec25d…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 7 · 270 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 78 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Diltiazem Hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DILTIAZEM HYDROCHLORIDE 360 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination OLH94387TE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 830874 Internal RxNorm lookup 830877 Internal RxNorm lookup 830879 Internal RxNorm lookup 830882 Internal RxNorm lookup 830897 Internal RxNorm lookup 830900 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68682-708-30 Diltiazem Hydrochloride 30 in 1 BOTTLE TABLET, EXTENDED RELEASE 30 10 68682-708-90 Diltiazem Hydrochloride 90 in 1 BOTTLE TABLET, EXTENDED RELEASE 90 10
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Diltiazem Hydrochloride ACTIVE INGREDIENT OLH94387TE DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 Diltiazem ACTIVE MOIETY EE92BBP03H DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 carnauba wax INACTIVE INGREDIENT R12CBM0EIZ DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 ethyl acrylate and methyl methacrylate copolymer (2:1; 750000 mw) INACTIVE INGREDIENT P2OM2Q86BI DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 microcrystalline wax INACTIVE INGREDIENT XOF597Q3KY DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 polydextrose INACTIVE INGREDIENT VH2XOU12IE DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 polyethylene glycols INACTIVE INGREDIENT 3WJQ0SDW1A DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 POVIDONES INACTIVE INGREDIENT FZ989GH94E DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 sucrose stearate INACTIVE INGREDIENT 274KW0O50M DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 talc INACTIVE INGREDIENT 7SEV7J4R1U DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68682-708 DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS) TABLET, EXTENDED RELEASE [OCEANSIDE PHARMACEUTICALS] 9 Current NDC, Legacy NDC, 2 package rows 20230331_73b3607a-99d0-44d8-92ef-0074684c9d7d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68682-708-90 68682070890 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-90) 2014-02-06 0000-00-00 No No Current